Bright Minds Bio Follows A Therapeutic Approach To Healing Brain Health Disorders

Dysfunction in the serotonergic circuit of the brain is the root cause of a lot of psychiatric and neurological illnesses. This means, if serotonin (5-HT) is regulated, it can resolve a lot of brain health issues. Bright Minds Biosciences is the only biotechnology company that focuses on restoring serotonin levels in the brain with the use of effective psychoactive compounds.

Even though SSRIs (Selective serotonin reuptake inhibitors) also target the serotonergic receptors, they have a lot of side-effects. Some of those are:

1. Dizziness

2. Nausea

3. Dry Mouth

4. Hallucinations

5. Confusion

6. Agitation

7. Mood swings, etc.

Even psychoactive compounds exhibit a lot of such adverse effects; however, these drugs have more effect on the serotonin levels, as they target specific serotonin receptors. Bright Minds has a team of researchers, discovery scientists, and expert chemists who are constantly experimenting with molecular models of serotonergic compounds such as magic mushrooms.

Our team at Bright Minds Bio has multiple patents on re-designed molecular compounds of psychoactive drugs that can help people with neurological, neuropsychiatric, and chronic pain problems. And our drugs can treat patients with brain disorders without any side-effects.

Bright Minds Bio Brings To You - The Therapeutic Use Of Magic Mushrooms!

Seldom do people imagine psychiatrists prescribing psychedelics as a potential treatment for mental health problems.

Still, the general population feels that Magic Mushrooms is most popularly used amongst hippies, at Dorms, and concerts.

However, scientific researches have already proved that psychedelics such as psilocybin, DMT, and LSD, aren’t at all addictive. In fact, it is used by many tribal and spiritual population of the world, in prescribed amounts, as a treatment for brain health issues.

Bright Minds Chief Medical Officer, Dr. Revati Shreeniwas, has been studying the effect of psychedelics. Her studies have led to the approval of many drugs such as Natrecor, Tracleer Lexiscan, Esbriet, Talzenna, and Sunosi.

The next step for Bright Minds Biosciences, in collaboration with our CMO, CSO, and other top officials, is to create more serotonin selective agents. These selective compounds will target individual 5-HT receptors in the brain.

By increasing the therapeutic effects of psychedelics, such as psilocybin that are found in ‘Magic Mushrooms,’ and by minimizing their side-effects, we aim at helping patients who suffer from:


1. BPSD

2. MMD

3. Epilepsy

4. Pharmacoresistant Epilepsy

5. Focal Epilepsy

6. Chronic Pain

7. PTSD

8. Parkinson’s

9. Alzheimer’s

10. OCD

11. Substance Abuse

Next-Generation Drugs For Better Mental Health

Psychedelics have been tabooed for most people all around the globe. And Bright Minds Bio will do everything to prove that mother nature has provided such drugs for special purposes. The brain is a complex organ, and so is its treatment.

That’s why we have found out the precise molecular design of such powerful herbs that can really help people overcome serious mental illnesses such as Pharmacoresistant Epilepsy.

We step in when all methods have failed; hence, we ARE the next-generation cure for better mental health.Contact us, to know more about our latest research, and patents.

Report this Page